Skip to main content
Find more clinical trials

Alzheimer's Disease Genetics Study

Start: June 2002
End: July 2026
Enrollment: 3000

What Is This Study About?

This study will identify and analyze genes associated with late-onset Alzheimer's disease. Researchers will collect genetic material from families in the United States in which two or more two living, blood-related individuals that have been diagnosed with or are showing symptoms of Alzheimer's disease or dementia. Participants will provide biological samples, such as tissue or blood. The biological samples and data from participants will be made available to qualified researchers. Results of individual tests are not available to participants or family members. For eligible families that do not live near a participating site, other arrangements may be possible to allow participation.

Do I Qualify To Participate in This Study?

Minimum Age: N/A

Maximum Age: N/A

Must have:

  • Two living family members diagnosed with Alzheimer's disease or other dementia with any age of onset
  • Biological samples available, such as fresh blood, immortalized lymphoblastic cell lines, or 3-5 grams of frozen cerebral cortex (fixed samples are not accepted)

Must NOT have:

  • Member of a family included in the National Institute of Mental Health AD Genetics Sib Pair collection

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

Study Contact
Study Coordinator

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Participants are being recruited from all over the United States
Multiple Locations, IN 46202
NCRAD Study Coordinator

Who Sponsors This Study?

Lead: Indiana University

Collaborator Sponsor

  • National Institute on Aging (NIA)

Source: ID: NCT00064870